kalinox: Clinical Trials

6 trials of kalinox, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 2 Not applicable, 2 Phase 2, 1 Phase 1, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2
Phase 22Completed 2
Phase 11Completed 1
Phase 31Completed 1
Phase 41Completed 1

Follow kalinox: new trials by email Literature Review of kalinox trials Research Report on kalinox

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Brain Reactivity to Nitrous Oxyde in Depression : an MRI and Ultrasound Study (PROTOBRAIN Pilote)
Nitrous Oxide-Oxygen, Tissue Pulsatility Imaging - TPI, Magnetic Resonance Imaging - MRI - Treatment Resistant Depression, Nitrous Oxyde
Not applicableCompletedUniversity Hospital, Tours302020-02-202025-12-23
Contribution of Hypnosis to Anxiety and Pain in Brachytherapy Patients
formal hypnosis, Kalinox - Cancer, Brachytherapy
Phase 2CompletedInstitut de Cancérologie de Lorraine682019-11-022026-09-01
Interest of Virtual Reality in the Management of Anxiety and Pain Related to Post-cardiac Surgery Care
Virtual Reality, Kalinox - Surgery, Cardiac
Not applicableCompletedCMC Ambroise Paré2002019-09-262026-04-08
Therapeutic Virtual Reality : Impact on the Management of Pain and Anxiety Related to Hematology Care (REVEH)
Virtual Reality, Kalinox - Hematologic Neoplasms
Phase 2 / Phase 3CompletedWeprom1262018-09-062020-06-23
Hyperalgesia and Pain
Nitrous Oxide - Hyperalgesia
Phase 1CompletedAir Liquide Santé International202012-01-012025-09-11
Efficacy of Premixed Nitrous Oxide and Oxygen in Patient With Out-of-hospital Moderate Acute Pain
Premixed 50% nitrous oxide and oxygen (Kalinox), medical air - Acute Pain
Phase 4CompletedUniversity Hospital, Toulouse602010-02-012017-05-12

Conditions studied

Pain (2)  ·  Acute Pain (1)  ·  Anxiety Disorders (1)  ·  Depressive Disorder, Treatment-Resistant (1)  ·  Hematologic Neoplasms (1)  ·  Hyperalgesia (1)  ·  Neoplasms (1)

Sponsors

Air Liquide Santé International (1)  ·  CMC Ambroise Paré (1)  ·  Institut de Cancérologie de Lorraine (1)  ·  University Hospital, Toulouse (1)  ·  University Hospital, Tours (1)  ·  Weprom (1)

Countries

France (5)  ·  Germany (1)

Top investigators

Katell LE DU, MD (1)

Results publications

PMID 23406077, PMID 33983498, PMID 34735395, PMID 36790852, PMID 37592013, PMID 40883194

NIH funding

2018 (1)